| Synonyms: | |
| Status: | Approved (2019) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | M05BX06 |
| UNII: | 3VHF2ZD92J |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Sclerostin inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoporosis, Postmenopausal | 4 | D015663 | ClinicalTrials |
| Osteoporosis | 4 | D010024 | ClinicalTrials |
| Fractures, Bone | 2 | D050723 | ClinicalTrials |
| Bone Diseases, Metabolic | 1 | D001851 | ClinicalTrials |
| Osteogenesis Imperfecta | 1 | D010013 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 909395-70-6 |
| ChEMBL | CHEMBL2107874 |
| FDA SRS | 3VHF2ZD92J |
| Guide to Pharmacology | 8092 |
CONTENTS